Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
Authors
Keywords
-
Journal
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-24
DOI
10.1007/s10162-020-00759-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lovastatin protects against cisplatin-induced hearing loss in mice
- (2020) Katharine Fernandez et al. HEARING RESEARCH
- An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity
- (2019) K. Fernandez et al. HEARING RESEARCH
- Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
- (2019) Krishnansu S. Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection
- (2019) Anna Hucke et al. ARCHIVES OF TOXICOLOGY
- A case of idiosyncratic liver injury after oxaliplatin‐induced thrombocytopenia
- (2019) Shinji Honda et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Long term platinum-induced ototoxicity in pediatric patients
- (2018) Sofia Waissbluth et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients
- (2018) Sofia Waissbluth et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions
- (2017) Dawn Konrad-Martin et al. INTERNATIONAL JOURNAL OF AUDIOLOGY
- Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
- (2017) Sandeep Sheth et al. Frontiers in Cellular Neuroscience
- Cisplatin is retained in the cochlea indefinitely following chemotherapy
- (2017) Andrew M. Breglio et al. Nature Communications
- Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life
- (2016) Måns Stefansson et al. ACTA ONCOLOGICA
- Audiological Monitoring in Children Treated with Platinum Chemotherapy
- (2016) A.R. Fetoni et al. AUDIOLOGY AND NEURO-OTOLOGY
- Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study
- (2016) Eva Clemens et al. EUROPEAN JOURNAL OF CANCER
- In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity
- (2016) A. Roldán-Fidalgo et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Sudden hearing loss due to oxaliplatin use in a patient with colon cancer
- (2016) M. Güven Güvenç et al. JOURNAL OF CHEMOTHERAPY
- Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
- (2016) Robert D. Frisina et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations
- (2016) Anna Hucke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
- (2015) Jing Yu et al. MEDICINE
- Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity
- (2015) Claudia Lanvers-Kaminsky et al. PHARMACOGENOMICS
- Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures
- (2014) Pascal Dammeyer et al. ACTA OTO-LARYNGOLOGICA
- Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines
- (2014) Jeongho Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer
- (2014) Masahiro Uchida et al. International Journal of Clinical Oncology
- Incidence of platinum-induced ototoxicity in pediatric patients in Quebec
- (2014) Emilia Peleva et al. PEDIATRIC BLOOD & CANCER
- Oxaliplatin and ototoxicity: is it really safe for hearing?
- (2014) Salim YÜCE et al. Turkish Journal Of Medical Sciences
- Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
- (2014) Hyun Sun Woo et al. Cancer Research and Treatment
- Accumulation, Fractionation, and Analysis of Platinum in Toxicologically Affected Tissues after Cisplatin, Oxaliplatin, and Carboplatin Administration
- (2013) D. Esteban-Fernandez et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Sound preconditioning therapy inhibits ototoxic hearing loss in mice
- (2013) Soumen Roy et al. JOURNAL OF CLINICAL INVESTIGATION
- Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma
- (2013) Johnnie K. Bass et al. PEDIATRIC BLOOD & CANCER
- Understanding platinum-induced ototoxicity
- (2013) Thorsten Langer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention
- (2012) Jochen Schacht et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Oxaliplatin-related thrombocytopenia
- (2012) D. L. Jardim et al. ANNALS OF ONCOLOGY
- Carboplatin-Associated Ototoxicity in Children With Retinoblastoma
- (2012) Ibrahim Qaddoumi et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- (2012) Antonio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients
- (2012) Allison Yancey et al. PEDIATRIC BLOOD & CANCER
- Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients
- (2012) ALEXANDRA NITZ et al. Oncology Letters
- Role of organic cation transporters in drug-induced toxicity
- (2011) Giuliano Ciarimboli Expert Opinion on Drug Metabolism & Toxicology
- A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
- (2011) Charles H. Weissman et al. Journal of Thoracic Oncology
- Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer
- (2011) Xiao-Dong Li WORLD JOURNAL OF GASTROENTEROLOGY
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
- (2010) Giuliano Ciarimboli et al. AMERICAN JOURNAL OF PATHOLOGY
- Unilateral Hearing Loss Is Associated With Worse Speech-Language Scores in Children
- (2010) J. E. C. Lieu et al. PEDIATRICS
- Hearing Loss in Pediatric Oncology Patients Receiving Carboplatin-containing Regimens
- (2009) Jennifer B. Dean et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Can carboplatin replace cisplatin for intraperitoneal use?
- (2008) K. FUJIWARA INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
- (2008) V. Hellberg et al. JNCI-Journal of the National Cancer Institute
- The application of inductively coupled plasma mass spectrometry in clinical pharmacological oncology research
- (2008) Elke E.M. Brouwers et al. MASS SPECTROMETRY REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started